首页> 外国专利> Use of beta-glucans against biological warfare weapons and pathogens including anthrax

Use of beta-glucans against biological warfare weapons and pathogens including anthrax

机译:使用β-葡聚糖对抗生物战武器和包括炭疽病在内的病原体

摘要

The present invention provides a means to broadly protect the military and the public from injury from biological warfare weapons, particularly infective agents such as anthrax. Beta (1,3)-glucans, particularly whole glucan particles, PGG-Glucan, and microparticulate glucan, provide general immune enhancement, thereby increasing the body's ability to defend against a wide variety of biological threats. Beta (1,3)-glucans have been shown to increase the resistance to infection by anthrax and other infectious organisms when administered before and after infection. The anti-infective mechanism of β(1,3)-glucan appears to involve stimulation of the innate immune system through increased cytokine release and CR3 receptor activation. Beta (1,3)-glucan is pharmaceutically stable, relatively compact, and can also be used without significant side effects. Beta (1,3)-glucan can also enhance the effectiveness of other medical countermeasures such as antibiotics, vaccines, and immune antibodies.
机译:本发明提供了一种广泛地保护军队和公众免受生物战武器,特别是诸如炭疽之类的传染剂的伤害的手段。 β(1,3)-葡聚糖,特别是全葡聚糖颗粒,PGG-葡聚糖和微粒葡聚糖,可提供一般的免疫增强作用,从而增强人体防御多种生物威胁的能力。已显示,在感染前后使用β(1,3)-葡聚糖可增强对炭疽和其他传染性生物的感染抵抗力。 β(1,3)-葡聚糖的抗感染机制似乎涉及通过增加细胞因子释放和CR3受体激活来刺激先天免疫系统。 β(1,3)-葡聚糖是药物稳定的,相对紧凑,也可以使用而没有明显的副作用。 β(1,3)-葡聚糖还可以增强其他医学对策的有效性,例如抗生素,疫苗和免疫抗体。

著录项

  • 公开/公告号US8865679B2

    专利类型

  • 公开/公告日2014-10-21

    原文格式PDF

  • 申请/专利权人 GARY R. OSTROFF;

    申请/专利号US20100871541

  • 发明设计人 GARY R. OSTROFF;

    申请日2010-08-30

  • 分类号A61K31/716;C08B37;A61K31/715;A61K39/395;A61K45/06;

  • 国家 US

  • 入库时间 2022-08-21 16:05:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号